肝素市場依產品類型、劑型及地區分類

Heparin Market, By Product Type, By Dosage Form, By Geography

出版日期: 2026年01月27日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，肝素市值將達到 75 億美元，到 2033 年將達到 100 億美元，2026 年至 2033 年的複合年成長率為 4.8%。

報告覆蓋範圍		報告詳情
基準年：	2025	2026年市場規模：	75億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	4.80%	預計2033年價值：	100億美元

肝素是一種抗凝血劑，用於降低血液凝固能力，防止血管內形成有害血栓。它有時被稱為血液稀釋劑，儘管它實際上不會稀釋血液。肝素不能溶解已形成的血栓，但可以防止血栓增大並引發更嚴重的問題。藥用級肝素萃取自動物組織。肝素廣泛用於治療心臟疾病、肺動脈栓塞、深層靜脈栓塞症、心房顫動，以及預防體外膜氧合（ECMO）和心肺體外迴圈期間的血栓症形成。

市場動態

心臟疾病、肺動脈栓塞和深層靜脈栓塞症（ DVT）發生率的不斷上升是推動市場對肝素產品需求的主要因素之一。心肌梗塞（MI）是心臟疾病的主要併發症之一。根據美國心臟協會（AHA）2018年的報告，心臟疾病是美國心血管疾病死亡的首要原因（43.8%），其次是中風（16.8%）。根據美國疾病管制與預防中心（CDC）2015年的報告，美國每年約有90萬人罹患深層靜脈栓塞症。

儘管肝素在慢性疾病治療中應用廣泛，但其腸道吸收率低，必須經由靜脈注射或皮下注射給藥。此外，其抗凝血特性會帶來嚴重的出血風險。肝素也會誘發血小板減少性疾病（循環血小板數量減少）和超敏反應等疾病。這些因素可能會在預測期內阻礙肝素市場的發展。

本次調查的主要特點

本報告對肝素市場進行了詳細分析，包括其市場規模以及以 2017 年為基準年，2018 年至 2026 年預測期內的複合年成長率 (%)。
我們重點介紹各個細分市場的潛在商機，並說明該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
該報告根據以下參數對全球肝素市場的主要企業進行了分析：公司概況、財務績效、產品系列、地理覆蓋範圍、分銷策略、關鍵發展和策略。
本報告的研究結果將使企業負責人和經營團隊能夠就即將推出的產品、政府措施、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球肝素市場報告的目標受眾是業內各種相關人員，包括投資者、產品製造商、經銷商、肝素市場供應商、研究和諮詢公司、新參與企業和金融分析師。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第7章競爭情勢

Anselm Pharmaceuticals
Baxter International Inc.
B. Braun Melsungen AG
Bristol-Myers Squibb Co.
Dr. Reddy's Laboratories Ltd.
Fresenius SE &Co. KGaA
Leap Labchem Co.
LEO Pharma A/S
Pfizer, Inc.
Sanofi SA
Syntex SA
Teva Pharmaceutical Industries Ltd.
United Biotech（P）Ltd.

第8章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第9章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI2602

Heparin Market is estimated to be valued at USD 7,500 Mn in 2026 and is expected to reach USD 10,000 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 7,500 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.80%	2033 Value Projection:	USD 10,000 Mn

Heparin is an anticoagulant used to decrease the clotting ability of blood and help to prevent harmful clots from forming in blood vessels. It is sometimes referred as a blood thinner, although it does not actually thin the blood. Heparin does not dissolve already formed blood clots, but it can prevent the clots from becoming larger and causing more serious problems. Pharmaceutical-grade heparin is derived from animal tissue. Heparin is commonly used in the treatment of coronary heart disease, pulmonary embolism, deep vein thrombosis, and atrial fibrillation, and in the prevention of thrombosis during extracorporeal membrane oxygenation and cardiopulmonary bypass.

Market Dynamics

Rising cases of conditions such as coronary heart disease, pulmonary embolism, and deep vein thrombosis is one of the major factors for increased demand of heparin drugs in the market. Myocardial infarction (MI) is one of the major complications of coronary heart disease. According to the American Heart Association 2018 report, coronary heart disease is the leading cause (43.8%) of deaths due to cardiovascular disease in the U.S., followed by stroke (16.8%). As per the Centres for Disease Control and Prevention (CDC) 2015 report, deep vein thrombosis affects nearly 900,000 individuals in the U.S. each year.

Despite major applications in chronic conditions, heparin is poorly absorbed by the intestine, therefore it must be given intravenously or subcutaneously. Moreover, the drug creates a significant risk of excessive bleeding due to anticlotting effect. Heparin also induce conditions such as thrombocytopenia (reduced number of circulating platelets) and hypersensitivity reactions. These factors can hamper the heparin market, during the forecast period.

Key features of the study

This report provides in-depth analysis of the heparin market, market size (USD Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global heparin market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Anselm Pharmaceuticals, Baxter International Inc., B. Braun Melsungen AG, Bristol-Myers Squibb Co., Dr. Reddy's Laboratories Ltd., Fresenius SE & Co. KGaA, Leap Labchem Co., LEO Pharma A/S, Pfizer, Inc., Sanofi S.A., Syntex S.A., Teva Pharmaceutical Industries Ltd., and United Biotech (P) Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global heparin market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for heparin market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2026 - 2033)
- Unfractionated Heparin (UH)
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMW)
Dosage Form Insights (Revenue, USD Mn, 2026 - 2033)
- Injection
- Solutions
Regional Insights (Revenue, USD Mn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Key Players Insights
- Anselm Pharmaceuticals
- Baxter International Inc.
- B. Braun Melsungen AG
- Bristol-Myers Squibb Co.
- Dr. Reddy's Laboratories Ltd.
- Fresenius SE & Co. KGaA
- Leap Labchem Co.
- LEO Pharma A/S
- Pfizer, Inc.
- Sanofi S.A.
- Syntex S.A.
- Teva Pharmaceutical Industries Ltd.
- United Biotech (P) Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Global Heparin Market, By Product Type
- Global Heparin Market, By Dosage Form
- Global Heparin Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend

4. Global Heparin Market, By Product Type, 2020-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Unfractionated Heparin (UH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Low Molecular Weight Heparin (LMWH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Ultra-low Molecular Weight Heparin (ULMW)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

5. Global Heparin Market, By Dosage Form, 2020-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

6. Global Heparin Market, By Region, 2020 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Anselm Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
B. Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Dr. Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius SE & Co. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Leap Labchem Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LEO Pharma A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Syntex S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
United Biotech (P) Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies